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Abstract 
Objective: We aimed to characterize hypoglycaemia episodes and patients examined by a Pre-hospital Medical 
Emergency Unit (PH) and in the Emergency Department (ED) of our hospital.
Results: We identified 86 episodes of severe hypoglycaemia (PH: n 37; ED: n 49; both: n 12). Hypoglycaemia 
accounted for 4.7% of all emergency calls attended by the PH (n 793) and 0.11% of all ED episodes (n 54,366). Among 
episodes examined by the PH, 64.5% of involved patients had type 2 diabetes and 54.1% were not referred to the ED. 
Transportation of the patient to the ED was more likely in type 2 diabetes (p = 0.014). Among episodes evaluated in 
the ED 66.1% of the patients were more than 65 years old and 81.4% had type 2 diabetes. 66% of the patients were 
insulin treated. One-third of examined patients were admitted to the ward, the majority having type 2 diabetes.
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Introduction
Hypoglycaemia is a major barrier to the achievement of 
optimal glycaemic control in diabetes (DM) [1, 2]. It is 
one of the most common adverse effects associated with 
antidiabetic drugs and is usually recognized as being 
potentially harmful to people with diabetes [3, 4]. The 
ACCORD [5], ADVANCE [6] and VADT [7] trials dem-
onstrated an increase in mortality in the case of inten-
sively-treated patients with type 2 diabetes (T2DM). In 
analysing the reason for this, one of the main hypothesis 
is that mortality was associated with hypoglycaemia risk.
ADA [2] reports on the subject consider that severe 
hypoglycaemia is a condition which requires another 
person to actively administer carbohydrates, glucagon, or 
take other corrective actions. In type 1 diabetes (T1DM), 
the incidence of severe hypoglycaemia is 115 [8]–320 
[9] episodes/patient-year, and severe hypoglycaemia 
may be the cause of death of 4–10% [10] of patients. For 
individuals with T2DM, the risk of severe hypoglycaemia 
is lower. It mainly occurs in individuals that have been 
treated with secretagogues or insulin, in older patients 
with multiple comorbidities, recent hospitalization and 
polymedicated patients [2]. Hypoglycaemia in DM has 
been recognized as a driver for increased costs to health-
care systems.
In Portugal, data regarding hypoglycaemia is scarce 
[11] as there are no structured databases regarding emer-
gency episodes, and diabetes databases are based on 
appointment records which do not include information 
about hypoglycaemia [12]. However, in 2015, an esti-
mated 13.3% [12] of the population had DM and may be 
at risk of treatment induced hypoglycaemia. The authors 
intend to evaluate the prevalence of hypoglycaemia and 
treatment protocols implemented in the Emergency 
Department (ED) of a leading hospital, and also in the 
associated Pre-hospital Medical Emergency Unit (PH), 
as well as the criteria for admission to the ward. We will 
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Main text
Methods
We performed a retrospective cross-sectional study of 
individuals with DM examined in the Pre-hospital and/
or ED setting due to hypoglycaemia. Our data refers to 
episodes that took place between the 1st of January and 
the 31st of March, 2010, evaluated by the PH or in the 
ED of our hospital, which provides care in a large city in 
Portugal. We weren’t able to extend the study period due 
to software limitations. In Portugal, Pre-hospital Care 
is usually made by paramedic personnel. Some teams 
include medical doctors that can treat emergent situ-
ations in an outpatient basis, with no need to transport 
the patient to the hospital. All emergency episodes are 
documented in the Pre-hospital Emergency Unit file and/
or in the electronic health record software used in the 
Emergency Department–Alert©. We searched the files of 
the PH and the Alert© software for data on ED episodes, 
using the ICD-9 codes that are potentially associated with 
DM and its complications, or hypoglycaemia: 250 (diabe-
tes mellitus), 251 (other disorders of pancreatic internal 
secretion), 271 (disorders of carbohydrate transport and 
metabolism), 775.6 (hypoglycaemia) and 962 (poison-
ing by hormones and synthetic substitutes). We excluded 
patients without diabetes, as well as codification errors. 
We recorded the following variables: demographic data, 
type of diabetes, antidiabetic drugs, diabetes duration, 
chronic diabetes complications, comorbidities, presence 
of neurogenic or neuroglycopenic symptoms, Glasgow 
Coma Scale and glycaemia changes during the episode. 
We identified the episodes that resulted in admission to 
the Short Stay Unit (SSU), admission to the ward and the 
comorbidities that could be related with the decision to 
keep the patient in observation. The SSU is a ward where 
the patient can be kept for observation for less than 24 h, 
after which it is considered to be an admission to the 
ward.
We used Microsoft Office 2010 Excel and SPSS 20.0 
for statistical analysis. When applicable, we used the χ2 
and Mann–Whitney tests. The results were expressed 
as mean ± standard deviation or median [quartiles]. We 
considered p < 0.05 as significant.
Results
We reviewed 793 emergency calls evaluated by the PH, 
of which 37 were hypoglycaemia episodes (4.7%). We 
reviewed 54,366 ED episodes during the study period of 
which 15,517 were not associated with a definitive diag-
nosis and therefore were excluded from the analysis. 
Among the remaining 38,849 episodes, we found 102 
episodes, of which 32 were not associated with hypogly-
caemia, 8 episodes occurred in patients without diabetes 
and 1 episode took place in the ED. Forty-two episodes 
were diagnosed as “other specified hypoglycaemia” and 
19 as “hypoglycaemia, unspecified”—totalizing 61 epi-
sodes of hypoglycaemia (0.11% of the total ED episodes; 
0.16% among episodes with a definitive diagnosis). In 
total, we identified 86 episodes of severe hypoglycaemia: 
37 examined by the PH, of which 12 were referred to the 
ED and 49 episodes were examined in the ED that had 
not been previously examined by the PH. The episodes 
occurred with 84 patients, as 2 individuals had recurrent 
hypoglycaemia.
Pre‑hospital Medical Emergency Unit
Twenty episodes (54.1%) did not result in referral to the 
ED and 13 (35.1%) occurred between 24.00 and 08.00. 
The characterization of the examined patients is pre-
sented in Table 1. People with T1DM were significantly 
younger than patients with T2DM [40 years (35.0–42.5) 
vs 75 years (68.5–77.8); p = 0.000; Mann–Whitney test], 
however there were no significant differences in diabetes 
duration (p = 0.203). All individuals with T2DM treated 
with oral agents only were using sulphonylureas.
Mean glycemia at presentation was 32 ± 14.9  mg/dL 
and only one-third of patients referred neurogenic symp-
toms. There was a previous attempt to treat hypoglycae-
mia by a relative in six episodes (16.2%). Thirty-five cases 
were treated on site by a health care professional using 
hypertonic glucose. There was no reference to use of 
glucagon. Episodes involving patients with T2DM were 
more frequently associated with referral to the ED than 
those in individuals with T1DM [14 (70.0%) vs 3 (25.0%); 
p = 0.027; χ2 test]. Refusal of the patient was the reason 
why 17.6% of patients were not evaluated in the ED.
Emergency Department
Table  1 describes the detailed information of patients 
with hypoglycemia examined in the ED. There was a high 
prevalence of significant comorbidities, such as chronic 
kidney disease (n 21, 34.4%), heart disease (n 20, 32.8%), 
cerebrovascular disease (n 18, 29.5%), neoplastic disease 
(n 8, 13.5%) and dementia (n 7, 11.9%). Details on the use 
of oral agents can be found in Table 2. Nineteen patients 
were using sulphonylureas, of which 8 were using gliben-
clamide, 5 were using glimepiride and 4 were using gli-
clazide (missing 2).
Details on hypoglycaemia episodes in the ED can be 
found in Table  3. At the time of arrival to the ED, 30 
(49.2%) patients were hypoglycaemic (mean glycemia 
43 ± 16.4  mg/dL, 1 below 20  mg/dL). Among these, 16 
(26.2%) were diagnosed in the ED. None of the patients 
admitted in the ED whilst hypoglycaemic was previ-
ously evaluated by our PH. In 32 (52.4%) patients, the 
mean maximal glycaemia during the ED stay was higher 
than 250  mg/dL. There was a statistically significant 
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difference in Glasgow Coma Scale between patients that 
were admitted in the ED during nighttime and daytime 
[8.5 (3.0–15.0) vs 15.0 (13.5–15.0) respectively; p = 0.046; 
Mann–Whitney test].
Digestive system associated disease was the most com-
mon concurrent cause for hypoglycemia (n 17, 27.9%), 
followed by insulin administration error (n 8, 13.1%), 
acute kidney injury (n 7, 11.5%), skipped meal (n 7, 
11.5%) and urinary tract infection (n 6, 9.8%). Other pre-
cipitants account for 13 episodes (21.3%) and 11 (18.0%) 
had no identified cause.
Patients’ stay in the hospital
Among 19 patients admitted, 2 stayed in the SSU for 
more than 24 h and the remaining were admitted to the 
ward. In 19 patients, 18 had T2DM, of which 9 were using 
oral agents only—all with sulphonylurea—6 were only 
using insulin and 3 were treated with combined therapy. 
Of the patients admitted to the ward, 11 presented rea-
sons for admission other than hypoglycaemia: (1) com-
munity acquired pneumoniae (n 4), (2) worsening kidney 
function (n 5), (3) myocardial infarction or decompen-
sated heart failure (n 3), (4) stroke (n 1), (5) lower limb 
gangrene (n 1) and (6) social reasons (n 1).
Hospital stay median duration was 9  days (minimum 
3–maximum 130), according to the type and severity of 
comorbidities. 17 (89.4%) patients were discharged home 
and 2 patients died during hospital stay.
Follow up after discharge from the ED/ward
Since the time period of data analysis up to Septem-
ber 2013, 15 (25.4%) patients died. The median time lag 
between severe hypoglycaemia episode and death was 
9 months (minimum 4–maximum 21). Patients that died 
during follow-up had a mean age of 72.9 ± 11.69  years 
Table 1 Characterization of patients with hypoglycaemia examined by the PH (n 37) and in the ED (n 59)
OA oral agents, DM1 type 1 diabetes mellitus, DM2 type 2 diabetes mellitus, DM3 other causes of diabetes mellitus
Pre-hospital Emergency Unit Emergency Department
Age (years) Mean ± SD: 60.7 ± 18.36
Min–max: 27–84
> 65 years: 19 (51.3%)
Mean ± SD: 68.0 ± 15.26
Min–max: 23–93
> 65 years: 39 (66.1%)















History of diabetes complications – Yes: 35 (59.3%)
No: 24 (40.7%)




Antidiabetic agents Only OA: 5 (26.3%)
Only insulin: 9 (47.4%)
OA plus insulin: 5 (26.3%)
Missing: 18
Only OA: 20 (33.9%)
Only insulin: 30 (50.8%)
OA plus Insulin: 9 (15.2%)
Table 2 Use of oral agents in people with diabetes admit-
ted in the ED for hypoglycemia
DPPI DPP-IV inhibitor, SU sulphonylurea, TZD thiazolidinedione, AGI alpha-
glucosidase inhibitor
Subgroups Drug class combination n




Oral agents only, including SU Monotherapy 5
+Metformin 7
+DPPI 1
+DPPI and metformin 3
+Metformin and AGI 1
Subtotal 17
Oral agents plus insulin +Metformin 3
+Metformin and DPPI 2
+Metformin, DPPI and SU 1
+Metformina and AGI 1
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and severe comorbidities. Among these, vascular disease 
(n 9) and chronic kidney disease (n 7) were particularly 
prevalent.
Discussion
We found a significant prevalence of severe hypoglycae-
mia among patients evaluated by a PH. A study published 
in 2006 [13] found that hypoglycaemia is the most com-
mon reason for emergency calls related to diabetes or 
antidiabetic therapy, accounting for 51% of evaluations. 
We confirmed that the frequency of referral to the ED 
among patients with T2DM is significantly higher than 
among individuals with T1DM, as previously described 
[11].
In previous literature, the prevalence of severe hypogly-
caemia in the ED is 0.37–0.4% [14, 15]. We found a lower 
figure, which might be related to the fact that the previ-
ous studies took place several years ago, and that the pre-
scription pattern of antidiabetic drugs differed from that 
of 2010, as well as recommended glucose targets. In Por-
tugal, most new insulins are fully and most oral agents 
are partially reimbursed.
In one study [13], 93% of patients was using insulin 
and only 1 patient did not have documented hypogly-
caemia in the pre-hospital context. In our series, 54.4% 
of patients were using insulin (56.3% among individu-
als with T2DM) and 16 (26.2%) were diagnosed in the 
ED. It may be that, in our area, patients and their rela-
tives might not have sufficient therapeutic education for 
the prevention, identification and adequate management 
of hypoglycaemia episodes. It is necessary to determine 
what the difficulties are for pre-hospital diagnosis/evalu-
ation of hypoglycaemia.
Regarding hypoglycaemia treatment modality, IV glu-
cose was the preferred treatment while other authors 
[13] noted a high prevalence of glucagon-use. The same 
authors found that most patients arrived at the ED still 
suffering from hypoglycaemia. In our study, nearly half 
of the patients were admitted in that condition. This may 
be related to: (1) inadequate pre-hospital diagnosis; (2) 
referral of patients to the ED by relatives due to symp-
toms associated with undiagnosed hypoglycaemia; (3) 
the patient was unable to ingest carbohydrate and did 
not have access to IV glucose or glucagon. Every patient 
evaluated by our PH was adequately treated before arriv-
ing at the ED.
Regarding the use of hypoglycaemic drugs, insulin 
seems to be the most frequent agent associated with 
severe hypoglycaemia. Nineteen patients were using 
sulphonylureas and, amongst them, 17 were not using 
insulin.
The frequency of admission to the ward for prolonged 
observation was 31.1%, whilst Brackenridge [13] found an 
admission rate of 11%. There are probably regional differ-
ences in criteria for admission to the ward. There is often 
an association with intercurrent illness which may also 
be a factor responsible for the elevated reported costs of 
hypoglycaemia.
Donnelly [8] also found a high mortality after severe 
hypoglycaemia, which is suggestive of its value as a prog-
nostic factor. Despite not being able to determine the 
cause of death, the high prevalence of severe comorbidi-
ties in patients suffering severe hypoglycaemia is of rel-
evance [16].
Conclusions
We found that many patients aren’t adequately evalu-
ated and treated before being referred to the Emergency 
Department. Hypoglycemia is a frequent cause for emer-
gency calls and only a minority those is evaluated in the 
Emergency Department. Most individuals evaluated in 
this context use insulin.
Table 3 Characterization of severe hypoglycaemia epi-
sodes recorded in the Emergency Department (n 61)
Glycaemia (mg/dL) On site: 38 ± 13.7 (3 below 20 mg/dL)
Minimum–maximum: 20–68
ED arrival: 103 ± 80.5
Minimum–maximum: 20–349
 Patients evaluated by our PH: 
202 ± 82.6
Glasgow coma scale All episodes: 14.0 (5.5–15.0)
Nocturnal: 8.5 (3.0–15.0)
Diurnal: 15.0 (13.5–15.0)
Administration of treatment on 
site
Relative: 15 (24.6%)
Health professional: 26 (42.6%)
Type of treatment on site (avail-




Type of treatment in the ED 56 (91.8%) patients received any kind 
of treatment
 Per os: 2
 Hypertonic glucose: 23 (mean 
2.2 ± 0.79 vials)
 Glucose 5–10% solution: 31




Workup requested? Yes: 52 (85.2%)
No: 9 (14.8%)
Admission in the short stay unit Yes: 18 (29.5%)
No: 43 (70.5%)
ED stay duration (h) 17.2 ± 1.27
Discharge destination Home: 40 (65.6%)
Other facility: 2 (3.3%)
Ward: 19 (31.1%)
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Limitations
We found a significant number of ED episodes with 
unspecified diagnosis, which may arbor a number of 
incorrectly codified hypoglycaemia episodes. Episodes 
associated with specified consequences of hypoglycaemia 
may have been codified without reference to hypoglycae-
mia. We were not able to determine the prevalence of use 
of specific insulin treatment regimens. Causes of hypo-
glycaemia were determined by the treating physician. 
These results may not be generalizable to patients from 
other regions.
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